Henry Schein, Inc.  

(Public, NASDAQ:HSIC)   Watch this stock  
Find more results for hsic
-0.09 (-0.05%)
Jun 23 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 183.66 - 184.75
52 week 146.23 - 186.99
Open 184.37
Vol / Avg. 440,353.00/360,752.00
Mkt cap 14.60B
P/E 27.98
Div/yield     -
EPS 6.58
Shares 79.33M
Beta 1.10
Inst. own 93%
Aug 2, 2017
Q2 2017 Henry Schein Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Jun 15, 2017
Henry Schein Inc at Piper Jaffray Heartland Summit
Jun 14, 2017
Henry Schein Inc at William Blair Growth Stock Conference - Webcast
Jun 13, 2017
Henry Schein Inc at Goldman Sachs Global Healthcare Conference - Webcast
Jun 6, 2017
Henry Schein Inc at Jefferies Healthcare Conference - Webcast
May 31, 2017
Henry Schein Inc Annual Shareholders Meeting
May 22, 2017
Henry Schein Inc at UBS Global Healthcare Conference - Webcast
May 16, 2017
Henry Schein Inc at Bank of America Merrill Lynch Healthcare Conference - Webcast
May 9, 2017
Q1 2017 Henry Schein Inc Earnings Call - Webcast
May 9, 2017
Q1 2017 Henry Schein Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Apr '17) 2016
Net profit margin 5.07% 4.65%
Operating margin 6.64% 6.67%
EBITD margin - 8.46%
Return on average assets 8.76% 8.13%
Return on average equity 20.23% 17.85%
Employees 21,000 -
CDP Score - -


135 Duryea Rd
United States - Map
+1-631-8435500 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Henry Schein, Inc. is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. The technology and value-added services segment provides software, technology and other value-added services to healthcare practitioners. Its technology group offerings include practice management software systems for dental and medical practitioners and animal health clinics. The Company provides its services to dental practitioners and laboratories, animal health clinics and physician practices, as well as government and institutional healthcare clinics.

Officers and directors

Stanley M. Bergman Chairman of the Board, Chief Executive Officer
Age: 67
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
James P. Breslawski CPA President, Director; Chief Executive Officer of Henry Schein Global Dental Group
Age: 63
Bio & Compensation  - Reuters
Steven Paladino CPA Chief Financial Officer, Executive Vice President, Director
Age: 59
Bio & Compensation  - Reuters
Peter McCarthy President of Global Animal Health Group
Age: 57
Bio & Compensation  - Reuters
David C. McKinley President of Corporate Commercial Development Group, Chief Commercial Officer
Age: 64
Bio & Compensation  - Reuters
Bob Minowitz President, International Dental Group, EMEA Region
Age: 58
Bio & Compensation  - Reuters
Bridget A. Ross President of Global Medical Group
Age: 52
Bio & Compensation  - Reuters
Gerald A. Benjamin Chief Administrative Officer, Executive Vice President, Director
Age: 64
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Mark E. Mlotek Chief Strategic Officer, Executive Vice President, Director
Age: 61
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Karen N. Prange Executive Vice President; Chief Executive Officer of Global Animal Health, Medical and Dental Surgical Group
Age: 53
Bio & Compensation  - Reuters